Geode Capital Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $378M | Sell |
2,521,596
-987,287
| -28% | -$107M | 0.02% | 546 |
|
|
2026
Q1 | $324M | Buy |
3,508,883
+295,226
| +9% | +$29.6M | 0.02% | 562 |
|
|
2025
Q4 | $328M | Buy |
3,213,657
+277,001
| +9% | +$24.8M | 0.02% | 550 |
|
|
2025
Q3 | $184M | Buy |
2,936,656
+15,942
| +0.5% | +$867K | 0.01% | 734 |
|
|
2025
Q2 | $152M | Buy |
2,920,714
+13,088
| +0.5% | +$585K | 0.01% | 786 |
|
|
2025
Q1 | $124M | Buy |
2,907,626
+84,538
| +3% | +$3.65M | 0.01% | 844 |
|
|
2024
Q4 | $86.3M | Buy |
2,823,088
+868
| +0% | +$24.4K | 0.01% | 1093 |
|
|
2024
Q3 | $64.8M | Buy |
2,822,220
+29,686
| +1% | +$840K | 0.01% | 1266 |
|
|
2024
Q2 | $80.7M | Buy |
2,792,534
+150,724
| +6% | +$3.51M | 0.01% | 1056 |
|
|
2024
Q1 | $54.5M | Buy |
2,641,810
+128,107
| +5% | +$2.75M | 0.01% | 1294 |
|
|
2023
Q4 | $68M | Buy |
2,513,703
+119,039
| +5% | +$3.12M | 0.01% | 1131 |
|
|
2023
Q3 | $71M | Buy |
2,394,664
+134,621
| +6% | +$4.73M | 0.01% | 994 |
|
|
2023
Q2 | $80.9M | Buy |
2,260,043
+790,085
| +54% | +$22.7M | 0.01% | 922 |
|
|
2023
Q1 | $34.5M | Buy |
1,469,958
+49,258
| +3% | +$1.41M | ﹤0.01% | 1443 |
|
|
2022
Q4 | $38.6M | Buy |
1,420,700
+75,509
| +6% | +$3.46M | 0.01% | 1332 |
|
|
2022
Q3 | $72.4M | Buy |
1,345,191
+25,284
| +2% | +$1.3M | 0.01% | 841 |
|
|
2022
Q2 | $53.2M | Buy |
1,319,907
+23,141
| +2% | +$1.15M | 0.01% | 1072 |
|
|
2022
Q1 | $85.9M | Buy |
1,296,766
+45,605
| +4% | +$3.12M | 0.01% | 877 |
|
|
2021
Q4 | $125M | Buy |
1,251,161
+28,988
| +2% | +$3M | 0.02% | 709 |
|
|
2021
Q3 | $153M | Buy |
1,222,173
+132,569
| +12% | +$15.8M | 0.02% | 601 |
|
|
2021
Q2 | $135M | Buy |
1,089,604
+18,487
| +2% | +$2.49M | 0.02% | 652 |
|
|
2021
Q1 | $164M | Buy |
1,071,117
+31,720
| +3% | +$4.79M | 0.03% | 565 |
|
|
2020
Q4 | $134M | Buy |
1,039,397
+130,065
| +14% | +$15M | 0.02% | 588 |
|
|
2020
Q3 | $102M | Buy |
909,332
+158,735
| +21% | +$14.5M | 0.02% | 597 |
|
|
2020
Q2 | $60.9M | Buy |
750,597
+258,366
| +52% | +$20.8M | 0.01% | 790 |
|
|
2020
Q1 | $34.3M | Buy |
492,231
+36,065
| +8% | +$2.77M | 0.01% | 960 |
|
|
2019
Q4 | $35.6M | Buy |
456,166
+17,950
| +4% | +$1.29M | 0.01% | 1166 |
|
|
2019
Q3 | $28M | Buy |
438,216
+12,494
| +3% | +$1.1M | 0.01% | 1251 |
|
|
2019
Q2 | $36.8M | Buy |
425,722
+208,092
| +96% | +$15.9M | 0.01% | 1058 |
|
|
2019
Q1 | $16.7M | Sell |
217,630
-2,599
| -1% | -$144K | ﹤0.01% | 1553 |
|
|
2018
Q4 | $8.28M | Buy |
+220,229
| New | +$8.11M | ﹤0.01% | 1900 |
|
Other funds holding GH
VCM
VPM
DTC
Geode Capital Management's GH Position: Q2 2026 in Review
Geode Capital Management reduced its Guardant Health (GH) stake by 28% in Q2 2026, selling an estimated $107M and leaving 2,521,596 shares worth $378M. The position accounts for 0.02% of the portfolio, ranked #546.
Geode Capital Management first reported a position in GH in Q4 2018 and has held it in 31 quarters since. 458 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Geode Capital Management held 2,521,596 shares of Guardant Health worth $378M as of Q2 2026.
- Geode Capital Management sold 987,287 Guardant Health shares in Q2 2026, an estimated $107M.
- Guardant Health made up 0.02% of Geode Capital Management's portfolio in Q2 2026, its #546 holding.
- Geode Capital Management first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- 458 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.